Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ReGen takes CMI (collagen meniscus implant) to Italy with Xmedica deal

This article was originally published in Clinica

Executive Summary

In what signals its first step towards building an EU-wide distribution network, ReGen Biologics has appointed Xmedica, a private Milan-based company focused on tissue engineering products, as exclusive distributor of the ReGen collagen meniscus implant (CMI) in Italy. The deal, which runs through to 2007, also gives Xmedica a non-exclusive licence to market ReGen's SharpShooter tissue repair system. Financial details of the agreement were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT056851

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel